Daily FNArena News

A glance through the latest expert views and predictions about commodities with NAB seeing little correlation between commodity prices and QE, support for gold and copper, caution on silver, and gems as investments.

REVA Medical is developing bioresobable stents for treating coronary artery disease and Southern Cross rates the stock a Spec Buy.

The spot uranium price drifted back last week once the market gave up on its hope that a single buyer was prepared to buy all of the US government’s selling order.

A glance through the latest expert views and predictions about commodities with signs Japanese demand for coal and iron ore remains solid, nickel coming under pressure, changes to gold market dynamics and some mixed views on base metals.

The US has taken the first step towards LNG export; Shell is set to introduce floating LNG off WA; Woodside might have found the gas it needs for Pluto 2.

Daily update on share prices and consensus price targets.

The TechWizard warns investors should not underestimate downward potential for AUD/USD.

Prima Biomed is moving to late stage clinical trials for its CVac cancer vaccine and Southern Cross sees significant upside potential.

Don’t be fooled by short-term movements, says Keith Fitz-Gerald, the uptrend for commodities remains intact.

Daily update on share prices and consensus price targets.